Astma dziecięca
Patofizjologia i mechanizm
Astma dziecięca to heterogenna choroba zapalna dróg oddechowych, charakteryzująca się zmiennym ograniczeniem przepływu powietrza oraz objawami takimi jak świszczący oddech, kaszel i duszność. Patogeneza opiera się głównie na zapaleniu typu 2, gdzie limfocyty Th2 wydzielają cytokiny IL-4, IL-5 i IL-13, odpowiedzialne za produkcję IgE, rekrutację eozynofilów oraz nadprodukcję śluzu i skurcz oskrzeli. Proces zapalny przebiega w fazie sensytyzacji i ponownego kontaktu z alergenem, aktywując komórki tuczne i uwalniając mediatory takie jak histamina i leukotrieny. Nabłonek dróg oddechowych odgrywa kluczową rolę w inicjacji i podtrzymywaniu zapalenia, produkując cytokiny TSLP, IL-25 i IL-33, które aktywują wrodzone komórki limfoidalne typu 2 (ILC2). Nadreaktywność oskrzeli (BHR) i przebudowa dróg oddechowych, obejmująca przerost mięśni gładkich, zwłóknienie podnabłonkowe i hiperplazję komórek śluzowych, prowadzą do częściowo nieodwracalnego ograniczenia przepływu powietrza, szczególnie w ciężkiej, nieleczonej astmie.
Patogeneza astmy dziecięcej
Astma dziecięca to heterogenna choroba zapalna dróg oddechowych charakteryzująca się zmiennym ograniczeniem przepływu powietrza i utrzymującymi się objawami ze strony układu oddechowego, takimi jak świszczący oddech, kaszel, duszność i uczucie ściskania w klatce piersiowej. Patogeneza astmy dziecięcej jest złożona i obejmuje interakcję czynników genetycznych, środowiskowych oraz odpowiedzi immunologicznej, które wspólnie prowadzą do przewlekłego zapalenia, nadreaktywności oskrzeli i przebudowy dróg oddechowych.12
Rola zapalenia typu 2
Kluczowym elementem w patogenezie astmy dziecięcej jest odpowiedź zapalna typu 2. W tym typie zapalenia dominują limfocyty T pomocnicze typu 2 (Th2), które produkują cytokiny prozapalne, takie jak interleukina-4 (IL-4), IL-5 i IL-13. Te cytokiny odgrywają fundamentalną rolę w rozwoju astmy poprzez:34
- IL-4 – promuje produkcję przeciwciał IgE i różnicowanie limfocytów T w kierunku fenotypu Th25
- IL-5 – stymuluje wytwarzanie, dojrzewanie i rekrutację eozynofilów do płuc6
- IL-13 – powoduje nadprodukcję śluzu, pogarsza oczyszczanie śluzowo-rzęskowe i przyczynia się do skurczu oskrzeli7
Zapalenie typu 2 przebiega w dwóch głównych fazach:8
- Faza sensytyzacji: Komórki prezentujące antygen przetwarzają i prezentują alergeny limfocytom Th2, które wydzielają cytokiny typu 2 (IL-5, IL-4, IL-13).
- Faza kontaktu z alergenem: Przy ponownym kontakcie z tym samym alergenem, wiąże się on z IgE, co indukuje uwalnianie mediatorów z komórek tucznych (histamina, leukotrieny).
Aktywacja komórek tucznych prowadzi do szybkiej degranulacji i uwolnienia mediatorów zapalnych, takich jak histamina, prostaglandyna D2 (PGD2) i leukotrieny cysteinylowe (LTC4, LTCD4, LTCE4). Te mediatory wywołują skurcz mięśni gładkich dróg oddechowych i mogą stymulować odruchowe szlaki nerwowe.9
Rola epitelium oddechowego
Coraz więcej dowodów wskazuje na kluczową rolę nabłonka dróg oddechowych w inicjowaniu i podtrzymywaniu procesu zapalnego w astmie dziecięcej. Nabłonek oddechowy w odpowiedzi na urazy, infekcje i zanieczyszczenia produkuje cytokiny, w tym:1011
- Limfopoetyna zrębu grasicy (TSLP)
- IL-25
- IL-33
Te cytokiny pochodzące z nabłonka aktywują wrodzone komórki limfoidalne typu 2 (ILC2), które wytwarzają cytokiny Th2 i indukują zapalenie płuc typu 2. Uszkodzenie nabłonka w astmie powoduje zwiększone uwalnianie czynników wzrostu, w szczególności TGF-β1, który odgrywa istotną rolę w przebudowie dróg oddechowych.12
Dysfunkcyjny nabłonek dróg oddechowych jest bardziej podatny na czynniki środowiskowe, takie jak zwiększona przepuszczalność dla proteaz alergenów, infekcje wirusowe, czynniki drażniące i zanieczyszczenia. Wykazuje on również zaburzone mechanizmy naprawcze, co przyczynia się do utrzymywania się astmy.13
Nadreaktywność oskrzeli
Nadreaktywność oskrzeli (bronchial hyperresponsiveness, BHR) jest kluczową cechą patofizjologiczną astmy, charakteryzującą się przesadną odpowiedzią oskrzeli na różne bodźce fizyczne, chemiczne i środowiskowe. Stopień nadreaktywności oskrzeli zwykle koreluje z kliniczną ciężkością astmy.14
Mechanizmy zaangażowane w nadreaktywność oskrzeli obejmują:15
- Bezpośrednią stymulację mięśni gładkich dróg oddechowych
- Pośrednią stymulację przez substancje farmakologicznie aktywne z komórek wydzielających mediatory, takich jak komórki tuczne lub niemielinizowane neurony czuciowe
Przewlekłe zapalenie dróg oddechowych jest związane ze zwiększoną nadreaktywnością oskrzeli, co prowadzi do skurczu oskrzeli i typowych objawów, takich jak świszczący oddech, duszność i kaszel po ekspozycji na alergeny, czynniki drażniące, wirusy, zimne powietrze lub wysiłek fizyczny.16
Przebudowa dróg oddechowych
Przebudowa dróg oddechowych (airway remodeling) odnosi się do strukturalnych zmian w ścianach dróg oddechowych, które mogą wystąpić w wyniku przewlekłego zapalenia. Te zmiany obejmują:1718
- Przerost i hiperplazję mięśni gładkich
- Zwłóknienie podnabłonkowe i osadzanie kolagenu
- Hiperplazję komórek kubkowych
- Hiperplazję gruczołów śluzowych
- Zwiększoną waskularyzację dróg oddechowych
- Złuszczanie komórek nabłonka
Te zmiany strukturalne mogą prowadzić do częściowo nieodwracalnego ograniczenia przepływu powietrza w ciężkiej, nieleczonej astmie. Przebudowa dróg oddechowych jest wynikiem złożonej interakcji między nabłonkiem dróg oddechowych a leżącym pod nim mezenchymą, wynikającej z reaktywacji rozwojowej jednostki przejścia nabłonkowo-mezenchymalnego (EMTU), odpowiedzialnej za morfogenezę płuc w okresie płodowym.19
Wcześniej proponowano, że powtarzające się cykle zapalenia wynikające z ekspozycji na alergeny powodowały rozwój zmian strukturalnych dróg oddechowych. Jednak badania na noworodkowych modelach mysich i wyniki badań przekrojowych u dzieci z astmą wykazały, że kluczowe zmiany patofizjologiczne astmy alergicznej (nadreaktywność dróg oddechowych, zapalenie eozynofilowe i przebudowa dróg oddechowych) rozwijają się równolegle.20
Mechanizmy nieimmunologiczne w patogenezie astmy dziecięcej
Chociaż tradycyjnie astma jest postrzegana jako choroba zapalna, istnieją dowody sugerujące, że procesy niezależne od zapalenia również przyczyniają się do patogenezy astmy. Te mechanizmy obejmują:21
Rola kinaz, białek adaptorowych i mikroRNA
Badania wykazały, że kinazy białkowe, białka adaptorowe, mikroRNA, białko ORMDL3 i gasdermina B są nowo zidentyfikowanymi cząsteczkami, które napędzają progresję astmy, niezależnie od zapalenia.22
Szczególnie interesujące jest odkrycie, że nadaktywny gen ORMDL3, związany z 20-30% przypadków astmy dziecięcej, przerywa syntezę cząsteczek lipidowych zwanych sfingolipidami, które są częścią błon komórkowych. Chociaż badacze nie rozumieją jeszcze w pełni, dlaczego zmniejszona produkcja sfingolipidów prowadzi do astmy, ich eksperymenty wyraźnie wykazują związek między utratą tych lipidów a nadreaktywnością oskrzeli.23
Co ciekawe, ten szlak patogenetyczny nie jest związany z alergenami i nie ma nic wspólnego z zapaleniem, co sugeruje zupełnie nowy mechanizm rozwoju astmy.24
Rola układu nerwowego
Badania zaczynają wskazywać na udział układu nerwowego w patologii nawracających zaostrzeń astmy u dzieci. Badacze odkryli, że dzieci z częstymi zaostrzeniami astmy (FE) wykazywały unikalny wzrost ekspresji genów związanych z procesami układu nerwowego, podczas gdy drogi oddechowe dzieci bez częstych zaostrzeń charakteryzowały się ekspresją zapalenia alergicznego.25
Wyniki tych badań sugerują, że częstsze zaostrzenia astmy nie prowadzą do cięższych zaostrzeń, ale raczej do neuronalnej przebudowy dróg oddechowych, która przygotowuje je do reagowania w taki sam sposób, jak w przeszłości. Terapia ukierunkowana na szlaki neuronalne może być konieczna do odpowiedniego zapobiegania i/lub leczenia częstych zaostrzeń.26
Czynniki wpływające na rozwój astmy dziecięcej
Czynniki genetyczne
Genetyka odgrywa istotną rolę w astmie dziecięcej, przy czym wywiad rodzinny astmy pozostaje jednym z najważniejszych czynników ryzyka.27 Zidentyfikowano około 100 genów, które odgrywają rolę w rozwoju astmy.28
Na szczególną uwagę zasługuje locus 17q12-21, który był wielokrotnie potwierdzany i jest związany z astmą o wczesnym początku w dzieciństwie.29 Badania genomowe wykazały, że gen GSDMB w tym locus jest kluczowym genem związanym z kaskadą zapalną, co stanowi pierwszy przyczynowy model astmy oparty na genetycznym allelu ryzyka.30
Inne geny związane z astmą, które są wyrażane w nabłonku dróg oddechowych i leżącym pod nim mezenchymie, to IL-33 i TSLP, co wskazuje, że cytokiny alarmowe odgrywają centralną rolę w patogenezie astmy.31
Czynniki środowiskowe
Różnorodne czynniki środowiskowe zostały powiązane z patogenezą astmy u dzieci, w tym:32
- Alergeny (roztocza, koty, psy, trawy, pyłki, pleśń)
- Infekcje matki i palenie w czasie ciąży
- Narażenie na dym tytoniowy
- Sposób porodu (np. cesarskie cięcie)
- Wirusowe choroby układu oddechowego
- Otyłość
- Dieta
- Higiena
- Ekspozycja na substancje toksyczne
Szczególnie istotną rolę w rozwoju astmy odgrywają infekcje wirusowe dróg oddechowych we wczesnym dzieciństwie. Badania wykazały, że dzieci, u których rozwijają się objawy ze strony dolnych dróg oddechowych podczas infekcji wirusem syncytialnym (RSV) we wczesnym okresie życia, mają zwiększone ryzyko rozwoju objawów podobnych do astmy w wieku szkolnym.33
Zanieczyszczenie powietrza jest kolejnym ważnym czynnikiem środowiskowym związanym z astmą dziecięcą. Badania wykazały, że zarówno ostre, jak i przewlekłe narażenie na wysokie poziomy cząstek stałych (PM) jest związane z zaostrzeniem i zachorowalnością na astmę dziecięcą. Zanieczyszczenia powietrza mogą indukować trwały stan zapalny w płucach, mediowany przez układ odpornościowy.34
Hipoteza higieniczna
Jedną z przekonujących hipotez dotyczących przyczyny wzrostu liczby przypadków astmy i alergii w krajach zachodnich jest „hipoteza higieniczna”. Zakłada ona, że wzrost alergii u dzieci jest niezamierzoną konsekwencją poprawy higieny domowej, która zmniejsza częstość infekcji lub ekspozycję na produkty bakteryjne we wczesnym dzieciństwie.35
Potencjalnym łącznikiem między zmianami w higienie a chorobami alergicznymi jest wpływ, jaki poprawa higieny może mieć na naszą rdzenną mikrobiotę i rolę, jaką ta mikrobiota może odgrywać w kształtowaniu naszego układu odpornościowego.36
Hipoteza „zanikającej mikrobioty” głosi, że gdy jesteśmy mniej skolonizowani przez starożytne komensalne mikroorganizmy, które wspomagają wiele procesów, takich jak pobieranie witamin i odporność, stajemy się bardziej podatni na atak potencjalnych mikroorganizmów patogennych.37
Rola mikrobioty
Pojawia się coraz więcej dowodów na to, że mikrobiota potencjalnie odgrywa kluczową rolę w rozwoju chorób, w tym w patogenezie stanów dróg oddechowych, takich jak astma.38
Układ immunologiczny, funkcja płuc i mikrobiota w jelitach i drogach oddechowych rozwijają się równolegle, a dysbioza mikrobioty może być krytycznym czynnikiem w rozwoju astmy.39
Badania wykazały, że próbki mikrobioty nosowo-gardłowej (NPM) pobrane podczas ostrych infekcji dróg oddechowych wykazywały większą obfitość i były częściej zdominowane przez specyficzne jednostki taksonomiczne operacyjne (OTU) Streptococcus, Moraxella i Haemophilus, zgodne z oczekiwaniami dotyczącymi typowych patogenów układu oddechowego, takich jak S. pneumoniae, M. catarrhalis i H. influenzae.40
Fenotypy astmy dziecięcej
Astma dziecięca charakteryzuje się dużą heterogennością pod względem początku choroby, objawów, ciężkości, rokowania i odpowiedzi na leczenie. Dowody sugerują, że ta zmienność wynika z odrębnych mechanizmów patofizjologicznych, co doprowadziło do wyczerpujących badań mających na celu zrozumienie i scharakteryzowanie tych odrębnych jednostek, obecnie określanych jako endotypy.41
Fenotyp T2-high (eozynofilowy)
Najczęstszym i najlepiej opisanym endotypem jest T2-high (eozynofilowy), który występuje również w populacji dorosłych. Ten endotyp został opisany u dzieci z łagodną, umiarkowaną i ciężką astmą i charakteryzuje się wysokim stopniem atopii, zwiększoną liczbą eozynofilów (w plwocinie i surowicy), wysokim poziomem cytokin T2 (IL-4, IL-5 i IL-13) oraz wczesnymi oznakami przebudowy dróg oddechowych.42
Dominującym fenotypem zapalenia dróg oddechowych w astmie dziecięcej jest fenotyp eozynofilowy, niezależnie od ciężkości lub czasu trwania choroby.43
Fenotyp neutrofilowy
Endotyp zapalenia neutrofilowego został zidentyfikowany u dzieci z ciężką, lekooporną astmą (STRA) i charakteryzuje się naciekiem neutrofilowym dróg oddechowych, gdzie implikowany jest zmieniony profil immunologiczny Th1 i/lub Th17.44
IL-17 odgrywa ważną rolę w astmie z niskim poziomem Th2. Wyższe poziomy IL-17 są znajdowane w surowicy, plwocinie i płynie z płukania oskrzelowo-pęcherzykowego (BALF) pacjentów z astmą, co jest związane z ciężkością astmy.45
Cytokiny IL-17 mogą stymulować komórki nabłonkowe i fibroblasty do uwalniania chemotaktycznych czynników przyciągających neutrofile CXCL1/5/8 i czynnika stymulującego kolonie granulocytów i makrofagów, które rekrutują neutrofile do płuc. Ponadto IL-17A, ale nie IL-17F, wzmacnia skurcz mięśni gładkich dróg oddechowych, migrację i proliferację, co sprzyja nadreaktywności dróg oddechowych i ich przebudowie.46
Różnice płciowe w astmie dziecięcej
Istnieją wyraźne różnice płciowe w epidemiologii astmy dziecięcej. Chłopcy są bardziej narażeni na rozwój astmy niż dziewczynki, ale ten wzorzec odwraca się po okresie dojrzewania. Wskazuje to, że czynniki specyficzne dla płci, takie jak wahania poziomów hormonów, odgrywają rolę w patogenezie choroby.47
Obserwowane różnice płciowe w częstości występowania astmy u dzieci poniżej 18 roku życia w USA (9,2% u chłopców w porównaniu do 7,2% u dziewcząt) i u dorosłych (6,2% u mężczyzn w porównaniu do 10,4% u kobiet) sugerują, że zmiany hormonalne występujące w okresie dojrzewania mogą przyczyniać się do zwiększonej częstości występowania u dorosłych kobiet.48
Badania na modelach zwierzęcych sugerowały udział hormonów płciowych w mechanizmach zapalenia płuc i astmy. Ogólnie stwierdzono, że hormony jajnikowe zwiększają, a testosteron zmniejsza zapalenie dróg oddechowych w astmie, ale mechanizmy pozostają niejasne.49
Astma dziecięca a atopia
Rozwój sensytyzacji alergicznej jest kluczowym elementem patogenezy astmy u dzieci. Sensytyzacja może rozwinąć się na alergeny pokarmowe lub aeroalergeny i jest inicjowana na powierzchniach śluzówki lub barierowych, gdzie znajduje się warstwa nabłonkowa.50
Najsilniejszym czynnikiem ryzyka astmy jest rodzinny wywiad atopii. Zwiększa to ryzyko rozwoju alergicznego nieżytu nosa pięciokrotnie i ryzyko astmy trzykrotnie do czterokrotnie. U dzieci w wieku od 3 do 14 lat zarówno pozytywne testy skórne, jak i wzrost całkowitego IgE w surowicy są silnie związane z astmą.51
W klasycznej astmie alergicznej, limfocyty Th2 są aktywowane przez komórki dendrytyczne, a cytokiny uwalniane przez nie powodują aktywację układu odpornościowego humoralnego, z zwiększoną proliferacją komórek tucznych, eozynofilów i komórek dendrytycznych. Cytokiny uwalniane przez te komórki przyczyniają się do podstawowego procesu zapalnego i skurczu oskrzeli.52
Komórki B, produkując przeciwciała IgE po kontakcie z alergenem, odgrywają kluczową rolę w astmie alergicznej. Poza tym, wydzielające IL-10 podzestawy komórek B, mianowicie regulatorowe komórki B (Bregs), pełnią rolę w astmie alergicznej u myszy i ludzi.53
Astma alergiczna jest dominującą formą astmy w dzieciństwie, którą charakteryzuje sensytyzacja na konkretne alergeny, wysokie poziomy IgE, eozynofilia, odpowiedź immunologiczna typu 2 i zmniejszona ekspresja genów odporności wrodzonej.54
Kliniczne implikacje dla leczenia
Różnorodność patologii ciężkiej astmy dziecięcej pokazuje, że podejście „jeden rozmiar pasuje do wszystkich”, charakteryzujące wiele wytycznych, jest nieodpowiednie. Postępy w zrozumieniu podstawowej patogenezy i identyfikacji fenotypów klinicznych i endotypów molekularnych spowodowały przesunięcie w kierunku spersonalizowanego leczenia dzieci i młodzieży z astmą.55
Obecna wiedza na temat zapalnych fenotypów astmy dziecięcej została z powodzeniem zastosowana w leczeniu biologicznym dzieci z ciężką, oporną na terapię astmą i można oczekiwać, że pojawią się bardziej spersonalizowane opcje leczenia.56
Jednak nie cała ciężka astma dziecięca jest napędzana zapaleniem typu 2 i będzie reagować na strategie anty-IL5. Krytyczne określenie, co napędza patologię dróg oddechowych, jest kluczowe dla personalizacji leczenia.57
Badania nad biologikami, takimi jak dupilumab, który blokuje receptory IL-4 i IL-13, pokazują obiecujące wyniki w leczeniu astmy typu 2. Dupilumab wiąże się z receptorem IL-4, blokując wewnątrzkomórkowe sygnalizowanie IL-4 i IL-13, a także wiąże się z receptorem IL-13, zapobiegając wiązaniu receptora IL-13 z IL-13, jak również kompleksowaniu receptora IL-13 z kompleksem receptora IL-4.58
Ponadto, terapie ukierunkowane na szlaki neuronalne mogą być konieczne do odpowiedniego zapobiegania i/lub leczenia częstych zaostrzeń astmy, co podkreśla znaczenie zrozumienia różnych mechanizmów patogenetycznych astmy dziecięcej.59
Podsumowanie patogenezy astmy dziecięcej
Astma dziecięca jest heterogenną chorobą z różnymi fenotypami i endotypami, odzwierciedlającymi złożoną interakcję między czynnikami genetycznymi, środowiskowymi i immunologicznymi. Chociaż zapalenie typu 2 jest dominującym procesem patologicznym, coraz więcej dowodów wskazuje na rolę mechanizmów niezależnych od zapalenia, w tym szlaków neuronalnych i metabolizmu sfingolipidów.6061
Zrozumienie różnych mechanizmów patogenetycznych astmy dziecięcej ma kluczowe znaczenie dla opracowania ukierunkowanych strategii terapeutycznych, które będą skuteczne dla różnych fenotypów astmy. Postępy w identyfikacji biomarkerów i charakteryzacji endotypów astmy prowadzą do bardziej spersonalizowanego podejścia do leczenia, stwarzając realną możliwość całkowitego zapobiegania i wyleczenia tej przewlekłej choroby zapalnej.62
Dalsze badania są potrzebne, aby wyjaśnić konkretne mechanizmy działania różnych zanieczyszczeń powietrza, zidentyfikować polimorfizmy genetyczne, które modyfikują odpowiedź dróg oddechowych na zanieczyszczenia, i zbadać skuteczność nowych podejść profilaktycznych i/lub terapeutycznych dla osób z niskim poziomem enzymów antyoksydacyjnych. Ponadto, ponieważ zmiany epigenetyczne są dziedziczone podczas podziału komórek i mogą być przekazywane kolejnym pokoleniom, bardzo ważne jest wyjaśnienie roli epigenetyki w związku między zanieczyszczeniem powietrza a chorobą płuc u dzieci z astmą i zdrowych.63
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Pediatric Asthma – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK551631/
Pediatric asthma is characterized by variable expiratory airway limitation and persistent respiratory symptoms, including wheezing, coughing, shortness of breath, and chest tightness. […] Asthma often starts in childhood, with nearly half of all infants wheezing in their first year, and most developing persistent asthma by age 6. A complex interplay between genetic predisposition and environmental factors underscores its prevalence and severity. Additionally, patients commonly experience airway hyperresponsiveness and inflammation. […] The key to the development of clinical asthma lies in the activation of mast cells by cytokines and other mediators. Following initial allergen inhalation, affected patients exhibit an overexpression of the T-helper 2 subset (Th2) of lymphocytes relative to the Th1 type, leading to the production of specific IgE antibodies. The cytokines, including IL-4, IL-5, and IL-13, produced by Th2 lymphocytes promote IgE and eosinophilic responses in atopy.
- #2 Asthma: Practice Essentials, Background, Anatomyhttps://emedicine.medscape.com/article/296301-overview
Asthma is a common chronic disease worldwide and affects approximately 25 million persons in the United States. It is the most common chronic disease in childhood, affecting an estimated 6 million US children. The pathophysiology of asthma is complex and involves airway inflammation, intermittent airflow obstruction, and bronchial hyperresponsiveness. […] The pathophysiology of asthma is complex and involves airway inflammation, intermittent airflow obstruction, and bronchial hyperresponsiveness. The mechanism of inflammation in asthma may be acute, subacute, or chronic, and the presence of airway edema and mucus secretion also contributes to airflow obstruction and bronchial reactivity. Varying degrees of mononuclear cell and eosinophil infiltration, mucus hypersecretion, desquamation of the epithelium, smooth muscle hyperplasia, and airway remodeling are present.
- #3 Childhood asthma: pathogenesis and phenotypes – PubMedhttps://pubmed.ncbi.nlm.nih.gov/34711541/
In the pathogenesis of asthma in children there is a pivotal role for a type 2 inflammatory response to early life exposures or events. Interactions between infections, atopy, genetic susceptibility and environmental exposures (such as farmyard environment, air pollution and tobacco smoke exposure) influence the development of wheezing illness and the risk of progression to asthma. […] The immune system, lung function and the microbiome in gut and airways develop in parallel, and dysbiosis of the microbiome may be a critical factor in asthma development. Increased infant weight gain and preterm birth are other risk factors for development of asthma and reduced lung function. The complex interplay between these factors explains the heterogeneity of asthma in children. Subgroups of patients can be identified as phenotypes, based on clinical parameters, or endotypes, based on a specific pathophysiological mechanism. Paediatric asthma phenotypes and endotypes may ultimately help to improve diagnosis of asthma, prediction of asthma development and treatment of individual children, based on clinical, temporal, developmental or inflammatory characteristics. Unbiased, data-driven clustering, using a multidimensional or systems biology approach may be needed to better define phenotypes. The present knowledge on inflammatory phenotypes of childhood asthma has now been successfully applied in the treatment with biologicals of children with severe therapy-resistant asthma, and it is to be expected that more personalised treatment options may become available.
- #4 Current Understanding of Asthma Pathogenesis and Biomarkershttps://www.mdpi.com/2073-4409/11/17/2764
Asthma is a heterogeneous lung disease with variable phenotypes (clinical presentations) and distinctive endotypes (mechanisms). Over the last decade, considerable efforts have been made to dissect the cellular and molecular mechanisms of asthma. Aberrant T helper type 2 (Th2) inflammation is the most important pathological process for asthma, which is mediated by Th2 cytokines, such as interleukin (IL)-5, IL-4, and IL-13. Approximately 50% of mild-to-moderate asthma and a large portion of severe asthma is induced by Th2-dependent inflammation. Th2-low asthma can be mediated by non-Th2 cytokines, including IL-17 and tumor necrosis factor-α. There is emerging evidence to demonstrate that inflammation-independent processes also contribute to asthma pathogenesis. Protein kinases, adapter protein, microRNAs, ORMDL3, and gasdermin B are newly identified molecules that drive asthma progression, independent of inflammation.
- #5 Pediatric Asthma: Practice Essentials, Background, Pathophysiologyhttps://emedicine.medscape.com/article/1000997-overview
Chronic inflammation of the airways is associated with increased BHR, which leads to bronchospasm and typical symptoms of wheezing, shortness of breath, and coughing after exposure to allergens, environmental irritants, viruses, cold air, or exercise. In some patients with chronic asthma, airflow limitation may be only partially reversible because of airway remodeling (hypertrophy and hyperplasia of smooth muscle, angiogenesis, and subepithelial fibrosis) that occurs with chronic untreated disease. […] New insights in the pathogenesis of asthma suggest that lymphocytes play a role. Airway inflammation in asthma may represent a loss of normal balance between two „opposing” populations of T helper (Th) lymphocytes. Two types of Th lymphocytes have been characterized: Th1 and Th2. Th1 cells produce interleukin (IL)-2 and interferon- (IFN-), which are critical in cellular defense mechanisms in response to infection. Th2, in contrast, generates a family of cytokines (interleukin-4 [IL-4], IL-5, IL-6, IL-9, and IL-13) that can mediate allergic inflammation.
- #6 Current Understanding of Asthma Pathogenesis and Biomarkershttps://www.mdpi.com/2073-4409/11/17/2764
The pathological mechanisms of asthma are complex, varying in different phenotypes caused by different environmental triggers, ages, obesity, genetic factors, etc. In addition to airway inflammation, there is emerging evidence to suggest that inflammation-independent processes also contribute to asthma pathogenesis. […] Th2 inflammation has two major phases: 1. Sensitization: When allergens enter the low airways, antigen-presenting cells process and present the allergens to Th2 cells, which secret Th2 cytokines, including IL-5, IL-4, and IL-13. 2. Challenge: When the same allergens enter the airways, they bind to IgE, which induces mast cells to release mediators, such as leukotrienes (LTs), histamine, and ILs. In addition, IL-5 facilitates eosinophil production, maturation, and recruitment to the lungs. Eosinophils also release mediators, including major basic protein (MBP), which stimulates mast cells to release histamines and LTs.
- #7 Physiology & Pathophysiology | Childhood Asthmahttps://u.osu.edu/childhoodasthma/physiology-pathophysiology/
Bronchial hyperresponsiveness […] Fibroblast proliferation […] Epithelial injury […] Airway scarring. […] IL-8 […] Activates neutrophils […] Exaggerates the inflammatory response. […] IL-13 […] Lessens mucociliary clearance […] Boosts fibroblast secretion […] Contributes to bronchoconstriction. […] IL-17 […] Increases neutrophilic inflammation. […] IL-22 […] Triggers airway epithelial cells […] Further innate and adaptive immune responses […] Cytokine release […] Chemotaxis of inflammatory mediators. […] Late Asthmatic Response […] Occurs within 4-8 hours of early response and includes: […] Air trapping/continued bronchoconstriction […] Hyperinflation distal to obstructions […] Increases work of breathing and hypoxemia […] Leads to dyspnea from inability of air to release due to lingering obstruction.
- #8 Current Understanding of Asthma Pathogenesis and Biomarkershttps://www.mdpi.com/2073-4409/11/17/2764
The pathological mechanisms of asthma are complex, varying in different phenotypes caused by different environmental triggers, ages, obesity, genetic factors, etc. In addition to airway inflammation, there is emerging evidence to suggest that inflammation-independent processes also contribute to asthma pathogenesis. […] Th2 inflammation has two major phases: 1. Sensitization: When allergens enter the low airways, antigen-presenting cells process and present the allergens to Th2 cells, which secret Th2 cytokines, including IL-5, IL-4, and IL-13. 2. Challenge: When the same allergens enter the airways, they bind to IgE, which induces mast cells to release mediators, such as leukotrienes (LTs), histamine, and ILs. In addition, IL-5 facilitates eosinophil production, maturation, and recruitment to the lungs. Eosinophils also release mediators, including major basic protein (MBP), which stimulates mast cells to release histamines and LTs.
- #9 Pediatric Asthma – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK551631/
Additional allergen inhalation results in the cross-linking of allergen-specific IgE antibodies on the mast cell surface, causing rapid degranulation and release of histamine, prostaglandin D2 (PGD2), and cysteinyl leukotrienes such as LTC4, LTCD4, and LTCE4. […] This process triggers contraction of the airway smooth muscle within minutes and may also stimulate reflex neural pathways. Subsequently, an influx of inflammatory cells, such as monocytes, dendritic cells, neutrophils, T lymphocytes, eosinophils, and basophils, may cause delayed bronchoconstriction 7 hours later. […] Variable narrowing of the airway lumen throughout the tracheobronchial tree results in differing levels of airflow obstruction. Several factors contribute to this narrowing, including the contraction of airway smooth muscle, thickening of the airway wall due to edema, mucus plugging in the airways, and airway remodeling.
- #10 Current Understanding of Asthma Pathogenesis and Biomarkershttps://www.mdpi.com/2073-4409/11/17/2764
Recent studies demonstrated that the airway epithelium produces cytokines in response to injury, infection, and pollutants. These epithelial-derived cytokines include thymic stromal lymphopoietin (TSLP), IL-25, and IL-33. TSLP, IL-25, and IL-33 activate type 2 innate lymphoid cells (ILC2), which generate Th2 cytokines, such as IL-5 and IL-13 and induce Th2 lung inflammation. […] IL-17 has been proposed to play an important role in Th2-low asthma. Variants in the IL-17 pathway genes may be related to asthma pathology. Higher levels of IL-17 are found in serum, sputum, and bronchoalveolar lavage fluid (BALF) of patients with asthma, which is associated with asthma severity. […] The role of IL-17 cytokines in asthma is still under investigation. IL-17 cytokines may stimulate epithelial cells and fibroblasts to release neutrophil chemoattractants CXCL1/5/8 and granulocyteâmacrophage colony-stimulating factor, which recruit neutrophils to the lungs. Furthermore, IL-17A, but not IL-17F, enhances airway smooth muscle contraction, migration, and proliferation, which facilitates airway hyperresponsiveness (AHR) and airway remodeling, key characteristics of asthma. […] However, there is accumulating evidence to suggest that inflammation-independent processes are also associated with asthma progression. For instance, recent studies demonstrate that protein kinases, adapter proteins, and other molecules contribute to asthma pathogenesis.
- #11 Asthma: Pathogenesis and Phenotypes | Thoracic Keyhttps://thoracickey.com/asthma-pathogenesis-and-phenotypes/
The release of epithelial cytokines, particularly IL-25, IL-33, and thymic stromal lymphopoietin (TSLP), appears to be the key upstream event that initiates type 2 immune responses and the allergic inflammatory environment in asthma. […] The mechanisms of persistent type 2 immune responses in asthma are not well understood. One possibility is that aberrant immune programs become fixed because they are established during critical time windows in early life when the immune system is plastic. […] Current concepts hold that upstream events in the airway epithelium involving master regulators such as IL-33 result in increased activity of type 2 cytokines in the airway, secreted mainly by CD4 + T cells, and driving a cascade of downstream events, including IgE-mediated hypersensitivity, activation of airway epithelial cells, chemoattraction of effector cells (mast cells, eosinophils, and basophils), and remodeling of the epithelium and subepithelial matrix.
- #12 Airway epithelial dysfunction contributes to the pathogenesis of asthma – MedCrave onlinehttps://medcraveonline.com/JLPRR/airway-epithelial-dysfunction-contributes-to-the-pathogenesis-of-asthma.html
The structural changes in the airways can be detected by bronchial biopsy histopathology, and non-invasively by computed tomography (CT) as thickening of the airway wall, increase in wall area (WA), and WA%, and is accompanied by greater centrilobular air trapping compared with health controls. The lung structural changes contribute to the severity of asthma, and correlates with lung function abnormalities. Airways remodeling is due to immune responses orchestrated by pro-fibrotic cytokines, such as interleukin-13 (IL-13), IL-25, IL-33, and TSLP secreted by Th2 cells, ILC2, eosinophils, basophils, mast cells, and also by epithelial cells. Epithelial injury in asthmatic patients promotes increased release of growth factors secreted by immune and structural cells, such as TGF-1, which plays an important role in airway remodeling.
- #13 Airway epithelial dysfunction contributes to the pathogenesis of asthma – MedCrave onlinehttps://medcraveonline.com/JLPRR/airway-epithelial-dysfunction-contributes-to-the-pathogenesis-of-asthma.html
Airway epithelial dysfunction contributes to the pathogenesis of asthma. Asthma is a significant public health problem, affecting more than 358 million individuals globally, and it is the most common chronic inflammatory respiratory disease in children. There are several distinct immunopathological pathways, and many immune and structural cells in the airways involved in the pathophysiology of asthma. The roles of type 2 T helper cells (Th2), innate lymphoid cells group 2 (ILC2), dendritic cells, mast cells, and eosinophils are well established in the pathogenesis of asthma. However, the part played by structural cell such as the epithelial sentinel cells is not fully understood. […] Airway dysfunction plays a central role in sensitization to allergens and pathogenesis of asthma. Epithelial damage occur in all phenotypes of asthma, and in childhood asthma, suggesting that epithelial dysfunction occurs early in the pathogenesis of the disease. Impaired epithelial barrier function renders the airway vulnerable to early life virus infections, which prime immature dendritic cells (DCs) toward directing Th2 responses, and local allergen sensitization. Dysfunctional airway epithelium is susceptible to environmental insults, such as increased permeability to allergen proteases, viral infections, chemical irritants, and pollutants. It exhibits impaired repair responses which contribute to persistent asthma. Continued airway injury and repair lead to increase in deposition of extracellular matrix (ECM) proteins, such as collagens, laminin, lumican, fibronectin, and tenascin in the epithelial lamina reticularis. This promotes subepithelial fibrosis, thickening and non-compliant airway wall, and fixed airflow obstruction.
- #14 Asthma: Practice Essentials, Background, Anatomyhttps://emedicine.medscape.com/article/296301-overview
The presence of airway hyperresponsiveness or bronchial hyperreactivity in asthma is an exaggerated response to numerous exogenous and endogenous stimuli. The mechanisms involved include direct stimulation of airway smooth muscle and indirect stimulation by pharmacologically active substances from mediator-secreting cells such as mast cells or nonmyelinated sensory neurons. The degree of airway hyperresponsiveness generally correlates with the clinical severity of asthma. […] The mechanism of inflammation in asthma may be acute, subacute, or chronic, and the presence of airway edema and mucus secretion also contributes to airflow obstruction and bronchial reactivity. Varying degrees of mononuclear cell and eosinophil infiltration, mucus hypersecretion, desquamation of the epithelium, smooth muscle hyperplasia, and airway remodeling are present.
- #15 Asthma: Practice Essentials, Background, Anatomyhttps://emedicine.medscape.com/article/296301-overview
The presence of airway hyperresponsiveness or bronchial hyperreactivity in asthma is an exaggerated response to numerous exogenous and endogenous stimuli. The mechanisms involved include direct stimulation of airway smooth muscle and indirect stimulation by pharmacologically active substances from mediator-secreting cells such as mast cells or nonmyelinated sensory neurons. The degree of airway hyperresponsiveness generally correlates with the clinical severity of asthma. […] The mechanism of inflammation in asthma may be acute, subacute, or chronic, and the presence of airway edema and mucus secretion also contributes to airflow obstruction and bronchial reactivity. Varying degrees of mononuclear cell and eosinophil infiltration, mucus hypersecretion, desquamation of the epithelium, smooth muscle hyperplasia, and airway remodeling are present.
- #16 Asthma: Practice Essentials, Background, Anatomyhttps://emedicine.medscape.com/article/296301-overview
Chronic inflammation of the airways is associated with increased bronchial hyperresponsiveness, which leads to bronchospasm and typical symptoms of wheezing, shortness of breath, and coughing after exposure to allergens, environmental irritants, viruses, cold air, or exercise. In some patients with chronic asthma, airflow limitation may be only partially reversible because of airway remodeling (hypertrophy and hyperplasia of smooth muscle, angiogenesis, and subepithelial fibrosis) that occurs with chronic untreated disease.
- #17 Bronchial Asthma: Etiology, Pathophysiology, Diagnosis and Managementhttps://austinpublishinggroup.com/pulmonary-respiratory-medicine/fulltext/ajprm-v9-id1085.php
Bronchial asthma is a chronic inflammatory disease of the respiratory passages, occurring with the participation of mast cells, eosinophils and T-lymphocytes, the release of a large number of inflammatory mediators. […] The main pathophysiological characteristics of asthma are inflammation and airway remodeling, which include goblet cell hyperplasia, subepithelial fibrosis, collagen deposition, mucosal gland, hyperplasia, smooth muscle hypertrophy, and changes in the extracellular matrix. These changes can result in immune system imbalance, eventually leading to airway hyperresponsiveness. […] Long-standing inflammation will damage airways, and induces airway remodelling, entailing subepithelial fibrosis under the basement membrane, smooth muscle hypertrophy, and submucosal gland hyperplasia. This results in intractable asthma, presenting irreversible airflow limitation and persistent airway hyperresponsiveness.
- #18 Asthma: pathophysiology, causes and diagnosis – The Pharmaceutical Journalhttps://pharmaceutical-journal.com/article/ld/asthma-pathophysiology-causes-and-diagnosis
If an attack is left untreated, eosinophils, T-helper cells and mast cells migrate into the airways. Excess mucus production caused by goblet cells plug the airway and, together with increased airway tone and airway hyperresponsiveness, this causes the airway to narrow and further exacerbates symptoms. […] There is some evidence to suggest that airway remodelling can occur if asthma is poorly controlled over a period of years. Chronic inflammation causes bronchial smooth muscle hypertrophy, the formation of new vessels and interstitial collagen deposition, which results in persistent airflow obstruction similar to that seen in patients with chronic obstructive pulmonary disease (COPD).
- #19 Airway epithelial dysfunction contributes to the pathogenesis of asthma – MedCrave onlinehttps://medcraveonline.com/JLPRR/airway-epithelial-dysfunction-contributes-to-the-pathogenesis-of-asthma.html
Furthermore, defective epithelial repair is characterized by overexpression of epidermal growth factor (EGF) with receptor activation, which correlates with disease severity. The extent of epithelial expression of EGF receptors correlates with immunoreactive CXCL8 (IL-8), a very potent chemoattractant for neutrophils, which is critical in the pathogenesis of neutrophilic asthma. There is clear evidence suggesting that epithelial cells play an active role in inducing structural changes in the airways, also termed as airway remodeling. Airway remodeling is due to complex interaction between the airway epithelium and the underlying mesenchyme, resulting from reactivation of the developmental epithelial-mesenchymal transition unit (EMTU), which is responsible for lung morphogenesis during fetal life.
- #20 The Immunopathogenesis of Asthma | Thoracic Keyhttps://thoracickey.com/the-immunopathogenesis-of-asthma/
It had been proposed that repeated cycles of inflammation resulting from allergen exposure resulted in the development of structural airway changes, however, experiments using a neonatal mouse model and findings from cross-sectional studies that have investigated asthma pathology in children have shown that the key pathophysiological changes of allergic asthma (airway hyperresponsiveness, eosinophilic inflammation, and airway remodeling) develop in parallel. […] The airway structural cells are not just altered in quantity in asthma, but they are immunologically active and have a fundamentally altered functional phenotype which contributes to asthma pathogenesis as well.
- #21 Current Understanding of Asthma Pathogenesis and Biomarkershttps://www.mdpi.com/2073-4409/11/17/2764
Recent studies demonstrated that the airway epithelium produces cytokines in response to injury, infection, and pollutants. These epithelial-derived cytokines include thymic stromal lymphopoietin (TSLP), IL-25, and IL-33. TSLP, IL-25, and IL-33 activate type 2 innate lymphoid cells (ILC2), which generate Th2 cytokines, such as IL-5 and IL-13 and induce Th2 lung inflammation. […] IL-17 has been proposed to play an important role in Th2-low asthma. Variants in the IL-17 pathway genes may be related to asthma pathology. Higher levels of IL-17 are found in serum, sputum, and bronchoalveolar lavage fluid (BALF) of patients with asthma, which is associated with asthma severity. […] The role of IL-17 cytokines in asthma is still under investigation. IL-17 cytokines may stimulate epithelial cells and fibroblasts to release neutrophil chemoattractants CXCL1/5/8 and granulocyteâmacrophage colony-stimulating factor, which recruit neutrophils to the lungs. Furthermore, IL-17A, but not IL-17F, enhances airway smooth muscle contraction, migration, and proliferation, which facilitates airway hyperresponsiveness (AHR) and airway remodeling, key characteristics of asthma. […] However, there is accumulating evidence to suggest that inflammation-independent processes are also associated with asthma progression. For instance, recent studies demonstrate that protein kinases, adapter proteins, and other molecules contribute to asthma pathogenesis.
- #22 Current Understanding of Asthma Pathogenesis and Biomarkershttps://www.mdpi.com/2073-4409/11/17/2764
Asthma is a heterogeneous lung disease with variable phenotypes (clinical presentations) and distinctive endotypes (mechanisms). Over the last decade, considerable efforts have been made to dissect the cellular and molecular mechanisms of asthma. Aberrant T helper type 2 (Th2) inflammation is the most important pathological process for asthma, which is mediated by Th2 cytokines, such as interleukin (IL)-5, IL-4, and IL-13. Approximately 50% of mild-to-moderate asthma and a large portion of severe asthma is induced by Th2-dependent inflammation. Th2-low asthma can be mediated by non-Th2 cytokines, including IL-17 and tumor necrosis factor-α. There is emerging evidence to demonstrate that inflammation-independent processes also contribute to asthma pathogenesis. Protein kinases, adapter protein, microRNAs, ORMDL3, and gasdermin B are newly identified molecules that drive asthma progression, independent of inflammation.
- #23 Common Childhood Asthma Not Rooted in Allergens, Inflammation | Columbia University Irving Medical Centerhttps://www.cuimc.columbia.edu/news/common-childhood-asthma-not-rooted-allergens-inflammation
Little is known about why asthma develops, how it constricts the airway, or why response to treatments varies among patients. […] Their report, in Science Translational Medicine, reveals that an overactive gene linked in 20 to 30 percent of patients with childhood asthma interrupts the synthesis of lipid molecules (known as sphingolipids) that are part of cell membranes found all over the body. […] Although the researchers do not yet understand why asthma results from reduced production of sphingolipids, their experiments clearly show a link between loss of these lipids and bronchial hyperreactivity, a key feature of asthma. […] What makes this pathway unique, investigators say, is that it is not related to allergens and has nothing to do with inflammation. […] Our model shows that asthma can result from having too little of a type of sphingolipids. This is a completely new pathway for asthma pathogenesis, says the studys senior author, Dr. Stefan Worgall, chief of the Pediatric Pulmonology, Allergy and Immunology Division at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
- #24 Common Childhood Asthma Not Rooted in Allergens, Inflammation | Columbia University Irving Medical Centerhttps://www.cuimc.columbia.edu/news/common-childhood-asthma-not-rooted-allergens-inflammation
Little is known about why asthma develops, how it constricts the airway, or why response to treatments varies among patients. […] Their report, in Science Translational Medicine, reveals that an overactive gene linked in 20 to 30 percent of patients with childhood asthma interrupts the synthesis of lipid molecules (known as sphingolipids) that are part of cell membranes found all over the body. […] Although the researchers do not yet understand why asthma results from reduced production of sphingolipids, their experiments clearly show a link between loss of these lipids and bronchial hyperreactivity, a key feature of asthma. […] What makes this pathway unique, investigators say, is that it is not related to allergens and has nothing to do with inflammation. […] Our model shows that asthma can result from having too little of a type of sphingolipids. This is a completely new pathway for asthma pathogenesis, says the studys senior author, Dr. Stefan Worgall, chief of the Pediatric Pulmonology, Allergy and Immunology Division at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
- #25 Airway Remodeling Creates Susceptibility to Frequent Asthma Exacerbations in Children – Research Horizonshttps://scienceblog.cincinnatichildrens.org/airway-remodeling-creates-susceptibility-to-frequent-asthma-exacerbations-in-children/
Asthma is a common allergic respiratory disease found in both children and adults. Yet the mechanisms underlying asthma pathogenesis and exacerbation frequency have been understudied, despite the high healthcare costs and morbidity rates associated with frequent asthma exacerbators in both populations. […] In a study led by first author Kieran Phelan and senior author Gurjit âNeeruâ Khurana Hershey, MD, PhD, researchers for the first time implicated the nervous system as having a role in recurrent exacerbation pathology in children with asthma. […] Among their findings, researchers discovered that FEs displayed a unique increase in gene signatures associated with nervous system processes, while the airways of non-FEs were characterized by the expression of allergic inflammation previously known to be involved in asthma.
- #26 Airway Remodeling Creates Susceptibility to Frequent Asthma Exacerbations in Children – Research Horizonshttps://scienceblog.cincinnatichildrens.org/airway-remodeling-creates-susceptibility-to-frequent-asthma-exacerbations-in-children/
The studyâs results suggest that more frequent asthma exacerbations donât lead to more severe exacerbations. Instead, repeated exacerbations result in neuronal airway remodeling that prime it to react the same way it has in the past. […] âOur findings highlight fundamental differences in these exacerbations and suggest that therapy targeting neuronal pathways may be necessary to adequately prevent and/or treat frequent exacerbations,â Khurana Hershey says.
- #27 Childhood asthma phenotypes and endotypes: a glance into the mosaic | Molecular and Cellular Pediatrics | Full Texthttps://molcellped.springeropen.com/articles/10.1186/s40348-023-00159-1
Asthma is an inflammatory lung disease that constitutes the most common noncommunicable chronic disease in childhood. Childhood asthma shows large heterogeneity regarding onset of disease, symptoms, severity, prognosis, and response to therapy. […] Evidence suggests that this variability is due to distinct pathophysiological mechanisms, which has led to an exhaustive research effort to understand and characterize these distinct entities currently designated as endotypes. […] This has resulted in many studies aiming at disentangling this heterogeneity using different and novel strategies. […] The heterogeneity in childhood asthma is due to different pathological mechanisms originating from the complex interplay between genetic, epigenetic, and environmental factors. […] Genetics also plays an important role in childhood asthma, where family history of asthma remains one of the most important risk factors.
- #28 Physiology & Pathophysiology | Childhood Asthmahttps://u.osu.edu/childhoodasthma/physiology-pathophysiology/
Chronic obstructive pulmonary disorder of the bronchial mucosa […] Episodes of bronchospasm and inflammation in the bronchial airways. […] Familial disease […] 100 genes identified as playing a role in the development. […] Early Asthmatic Responses […] IgE is activated, leading to: […] Degranulation of mast cells; […] Release of inflammatory mediators. […] IgE release causes: […] Vasodilation; […] Bronchospasm; […] Mucosal edema; […] Increased capillary permeability; […] Tenacious mucous secretions. […] Early Asthmatic Response: Immune Response Stimulation […] Dendritic cells […] Activated by antigen exposure to the bronchial mucosa […] Present antigen to CD4+ T cells. […] IL-4 […] B-cell activation […] Production of IgE. […] IL-5 […] Activation of eosinophils
- #29 Childhood asthma phenotypes and endotypes: a glance into the mosaic | Molecular and Cellular Pediatrics | Full Texthttps://molcellped.springeropen.com/articles/10.1186/s40348-023-00159-1
Noteworthy is the 17q12-21 locus, which has been replicated several times and is associated with early-onset asthma in childhood. […] The most common and best-described endotype is the T2-high (eosinophilic), which is also present in the adult population. This endotype has been described in children with mild, moderate, and severe asthma and is characterized by a high degree of atopy, increased eosinophils (in sputum and serum), high levels of T2 cytokines (IL-4, IL-5, and IL-13), and early signs of airway remodeling. […] The neutrophilic inflammatory endotype has been identified in children with STRA and is characterized by neutrophilic infiltration of the airways, where a Th1 or/and Th17 skewed immune profile has been implicated. […] In summary, different inflammatory endotypes have been described, and their detailed characterization may direct research towards new therapeutics and contribute to an adequate evidence-based selection of the best treatment for specific groups of asthmatic children.
- #30 ð¬ð§ Breakthrough in molecular mechanisms of childhood asthma » Luxembourg Institute of Healthhttps://www.lih.lu/en/event/breakthrough-in-molecular-mechanisms-of-childhood-asthma/
Airway diseases are still among the top 5 common causes of death and represent a major healthcare problem. Asthma is chronic obstructive disease that develops in some children in the very early life. Massive genotyping was conducted to identify risk alleles, but only revealed hits with n-numbers beyond thousands. One locus that stands out is the 17q21 locus carrying 9 genes. These genes are not specifically related to the immune system and their implication in asthma pathogenesis has been subject to many speculations. […] In the clinic it was observed that 17q21 children are initially suffering from viral infections. […] Surprisingly, the gene expression analysis revealed a clear picture, identifying GSDMB as the key gene, that is related to a downstream inflammatory cascade. In the presentation a pathogenesis pathway will be illustrated representing a first causative asthma model on a genetic risk allele.
- #31 Airway epithelial dysfunction contributes to the pathogenesis of asthma – MedCrave onlinehttps://medcraveonline.com/JLPRR/airway-epithelial-dysfunction-contributes-to-the-pathogenesis-of-asthma.html
Genetic and environmental factors play an important role in the pathogenesis of asthma. Environmental factors, such as allergens, microbacteria and viruses, irritant chemicals, pollutants, and environmental tobacco smoke interact with genes through epigenetic mechanisms that influence gene expression. The interaction between the airway epithelium and the underlying mesenchyme plays a central role in the pathophysiology of airway remodeling and pathogenesis of different phenotypes of asthma. There are several genes associated with asthma susceptibility expressed in the airway epithelium and the underlying mesenchyme. This indicates that responses at airway epithelial surface, and lung may play an important role in the pathogenesis of the disease. […] Notably, a few epithelial genes are shared among asthmatics, such as IL-33, and TSLP, indicating that alarmin cytokines play a central role in the pathogenesis of asthma. Furthermore, the expression of IL33 and TSLP are both elevated in the airways of patients with severe refractory asthma. The airway epithelium is the first cell layer of contact with environmental insults, such as allergens, microbes, viruses, chemical irritants, and pollutants. Dysfunctional airway epithelium orchestrate the inflammatory responses, and remodeling in patient with asthma. The epithelium is a suitable therapeutic target for discovery and development of new biologics, and therapeutic interventions for the treatment of severe uncontrolled asthma.
- #32 Childhood asthma: causes, risks, and protective factors; a role of innate immunityhttps://smw.ch/index.php/smw/article/download/1952/2784?inline=1
Childhood asthma is an umbrella of multifactorial diseases with similar clinical features such as mast cell and eosinophil infiltration causing airway hyper responsiveness, inflammation, and airway obstruction. There are various factors that are implicated in childhood asthma pathogenesis. A combined contribution of genetic predisposition, environmental insults, and epigenetic changes account for polarisation of the immune system towards T helper (Th) type 2 cell responses that include production of pro-inflammatory cytokines, IgE, and eosinophil infiltrates, shown to associate with asthma. […] The pathogenetic sources of asthma remain unknown and although genetic, environmental, and epigenetic factors have been identified, an effective therapeutic intervention is yet to be established. […] A number of diverse factors have been implicated in asthma pathogenesis in children. These include genetic predisposition (asthmatic parents), environmental stimuli during prenatal and early childhood that include allergens (mite, cat, dog, grass, pollen, and mould), maternal infection and smoking during pregnancy, environmental tobacco smoke, mode of birth delivery (i.e., Casearean section), viral respiratory illnesses, obesity, diet, hygiene, and toxic exposures.
- #33https://journals.lww.com/pidj/fulltext/2003/02001/respiratory_syncytial_virus_bronchiolitis_and_the.11.aspx
There is now convincing evidence that children who develop lower respiratory symptoms during infection with respiratory syncytial virus (RSV) in early life are at increased risk of developing asthma-like symptoms during the school years. […] Current evidence suggests that both genetic and environmental factors determine the type of immune response to the acute RSV infection and that this response, in turn, may affect the development of the control mechanisms involved in the regulation of airway tone. […] Despite these consistent characteristics, the mechanisms by which the pathogenesis of pediatric asthma evolves, in particular in association with certain predisposing factors to its development, such as RSV disease, require further elucidation. […] It has been proposed that in a genetically susceptible individual, the cytokine response to virus infection with high gene expression of interleukin (IL)-4 and IL-5, accompanied by low gene expression of IL-2 and interferon-gamma (IFN-gamma), may contribute to increased airway inflammation, pulmonary function deficits and influence long term outcomes, including postbronchiolitic wheezing and asthma.
- #34 The Role and Potential Pathogenic Mechanism of Particulate Matter in Childhood Asthma: A Review and Perspective. – Document – Gale Academic OneFilehttps://go.gale.com/ps/i.do?id=GALE%7CA619215437&sid=googleScholar&v=2.1&it=r&linkaccess=fulltext&issn=23148861&p=AONE&sw=w
Asthma, the most common chronic respiratory disease in children, affects numerous people worldwide. Accumulating evidence suggests that exposure to high levels of particulate matter (PM), either acutely or chronically, is associated with the exacerbation and incidence of pediatric asthma. However, the detailed pathogenic mechanisms by which PM contributes to the incidence of asthma remain largely unknown. […] In this short review, we summarize studies of relationships between PM and pediatric asthma and recent advances on the fundamental mechanisms of PM-related asthma, with emphases on cell death regulation and immune system responses. […] We further discuss the inadequacy of current studies and give a perspective on the prevention strategies for pediatric asthma.
- #35 Asthma: Pathogenesis and Phenotypes | Thoracic Keyhttps://thoracickey.com/asthma-pathogenesis-and-phenotypes/
One compelling hypothesis for the cause of the increase in asthma and allergies in Westernized countries is the hygiene hypothesis. This holds that the rise in allergies in children is an unintended consequence of the success of domestic hygiene in reducing the rate of infections or exposure to bacterial products in early childhood. […] One potential link between changes in hygiene and allergic disease is the effect that improved hygiene may have on our indigenous microbiota and the role this microbiota may play in shaping our immune system. […] In parallel with, and distinct from, the emergence of the Hygiene Hypothesis, there has been significant progress in documenting and understanding the role that viral respiratory tract infections play in the development of asthma. […] An accepted view now is that environmental stimuli in early childhood activate airway epithelial cells to initiate allergic airway responses and asthma in children who are susceptible because they have preexisting atopy, specific genetic risk factors, and other less well-understood vulnerabilities.
- #36 Asthma: Pathogenesis and Phenotypes | Thoracic Keyhttps://thoracickey.com/asthma-pathogenesis-and-phenotypes/
One compelling hypothesis for the cause of the increase in asthma and allergies in Westernized countries is the hygiene hypothesis. This holds that the rise in allergies in children is an unintended consequence of the success of domestic hygiene in reducing the rate of infections or exposure to bacterial products in early childhood. […] One potential link between changes in hygiene and allergic disease is the effect that improved hygiene may have on our indigenous microbiota and the role this microbiota may play in shaping our immune system. […] In parallel with, and distinct from, the emergence of the Hygiene Hypothesis, there has been significant progress in documenting and understanding the role that viral respiratory tract infections play in the development of asthma. […] An accepted view now is that environmental stimuli in early childhood activate airway epithelial cells to initiate allergic airway responses and asthma in children who are susceptible because they have preexisting atopy, specific genetic risk factors, and other less well-understood vulnerabilities.
- #37 The Microbiome and the Pathophysiology of Asthma | Respiratory Research | Full Texthttps://respiratory-research.biomedcentral.com/articles/10.1186/s12931-016-0479-4
The so-called hygiene hypothesis contends that exposure to soil, dust, microbes, antibiotics, vaccinations, farm animals and family size in addition to factors such as caesarean section birth versus vaginal birth and exclusive formula feeding versus breastfeeding can all in some part determine asthma risk. […] It is believed that microaspiration, which occurs in healthy individuals but has a higher prevalence in asthmatics, could in part explain the presence of oral microbiota in the lower lung. […] The disappearing microbiota hypothesis contends that as we become less colonised by ancient commensal microorganisms, which aid in a multitude of processes such as vitamin uptake and immunity, we become more susceptible to attack by potential pathogenic microorganisms. […] There is an emerging consensus that the microbiome potentially plays a critical role in disease development, including in the pathogenesis of airway conditions such as asthma.
- #38 The Microbiome and the Pathophysiology of Asthma | Respiratory Research | Full Texthttps://respiratory-research.biomedcentral.com/articles/10.1186/s12931-016-0479-4
The so-called hygiene hypothesis contends that exposure to soil, dust, microbes, antibiotics, vaccinations, farm animals and family size in addition to factors such as caesarean section birth versus vaginal birth and exclusive formula feeding versus breastfeeding can all in some part determine asthma risk. […] It is believed that microaspiration, which occurs in healthy individuals but has a higher prevalence in asthmatics, could in part explain the presence of oral microbiota in the lower lung. […] The disappearing microbiota hypothesis contends that as we become less colonised by ancient commensal microorganisms, which aid in a multitude of processes such as vitamin uptake and immunity, we become more susceptible to attack by potential pathogenic microorganisms. […] There is an emerging consensus that the microbiome potentially plays a critical role in disease development, including in the pathogenesis of airway conditions such as asthma.
- #39 Childhood asthma: pathogenesis and phenotypes – PubMedhttps://pubmed.ncbi.nlm.nih.gov/34711541/
In the pathogenesis of asthma in children there is a pivotal role for a type 2 inflammatory response to early life exposures or events. Interactions between infections, atopy, genetic susceptibility and environmental exposures (such as farmyard environment, air pollution and tobacco smoke exposure) influence the development of wheezing illness and the risk of progression to asthma. […] The immune system, lung function and the microbiome in gut and airways develop in parallel, and dysbiosis of the microbiome may be a critical factor in asthma development. Increased infant weight gain and preterm birth are other risk factors for development of asthma and reduced lung function. The complex interplay between these factors explains the heterogeneity of asthma in children. Subgroups of patients can be identified as phenotypes, based on clinical parameters, or endotypes, based on a specific pathophysiological mechanism. Paediatric asthma phenotypes and endotypes may ultimately help to improve diagnosis of asthma, prediction of asthma development and treatment of individual children, based on clinical, temporal, developmental or inflammatory characteristics. Unbiased, data-driven clustering, using a multidimensional or systems biology approach may be needed to better define phenotypes. The present knowledge on inflammatory phenotypes of childhood asthma has now been successfully applied in the treatment with biologicals of children with severe therapy-resistant asthma, and it is to be expected that more personalised treatment options may become available.
- #40 Dynamics of the upper airway microbiome in the pathogenesis of asthma-associated persistent wheeze in preschool children | bioRxivhttps://www.biorxiv.org/content/10.1101/222190v1.full
Repeated cycles of infection-associated lower airway inflammation drives the pathogenesis of persistent wheezing disease in children. […] This suggests underlying pathogenic interactions between allergic sensitization and antibacterial mechanisms. […] Understanding patterns of airway microbial colonization and its association with ARIs and subsequent wheeze phenotypes is an important first step towards the potential manipulation of the microbiome in treating or preventing acute or chronic respiratory disease. […] Our longitudinal data show the NPM can be highly dynamic within individuals. […] Throughout the first five years of life, NPM samples collected during ARIs showed a greater abundance of, and were more commonly dominated by, specific Streptococcus, Moraxella and Haemophilus OTUs, consistent with expectations regarding common respiratory pathogens S. pneumoniae, M. catarrhalis and H. influenzae to which these OTU sequences were most closely related.
- #41 Childhood asthma phenotypes and endotypes: a glance into the mosaic | Molecular and Cellular Pediatrics | Full Texthttps://molcellped.springeropen.com/articles/10.1186/s40348-023-00159-1
Asthma is an inflammatory lung disease that constitutes the most common noncommunicable chronic disease in childhood. Childhood asthma shows large heterogeneity regarding onset of disease, symptoms, severity, prognosis, and response to therapy. […] Evidence suggests that this variability is due to distinct pathophysiological mechanisms, which has led to an exhaustive research effort to understand and characterize these distinct entities currently designated as endotypes. […] This has resulted in many studies aiming at disentangling this heterogeneity using different and novel strategies. […] The heterogeneity in childhood asthma is due to different pathological mechanisms originating from the complex interplay between genetic, epigenetic, and environmental factors. […] Genetics also plays an important role in childhood asthma, where family history of asthma remains one of the most important risk factors.
- #42 Childhood asthma phenotypes and endotypes: a glance into the mosaic | Molecular and Cellular Pediatrics | Full Texthttps://molcellped.springeropen.com/articles/10.1186/s40348-023-00159-1
Noteworthy is the 17q12-21 locus, which has been replicated several times and is associated with early-onset asthma in childhood. […] The most common and best-described endotype is the T2-high (eosinophilic), which is also present in the adult population. This endotype has been described in children with mild, moderate, and severe asthma and is characterized by a high degree of atopy, increased eosinophils (in sputum and serum), high levels of T2 cytokines (IL-4, IL-5, and IL-13), and early signs of airway remodeling. […] The neutrophilic inflammatory endotype has been identified in children with STRA and is characterized by neutrophilic infiltration of the airways, where a Th1 or/and Th17 skewed immune profile has been implicated. […] In summary, different inflammatory endotypes have been described, and their detailed characterization may direct research towards new therapeutics and contribute to an adequate evidence-based selection of the best treatment for specific groups of asthmatic children.
- #43 The Immunopathogenesis of Asthma | Thoracic Keyhttps://thoracickey.com/the-immunopathogenesis-of-asthma/
Development of allergic sensitization is a key component of asthma pathogenesis in children. Sensitization may develop to food or aero-allergens and is initiated at mucosal or barrier surfaces where there is an epithelial layer. […] The cytokines and chemokines released following eosinophil degranulation promote longevity of eosinophils in tissues, which leads to the cyclical nature of signaling, activation, and survival. […] IL-5 is released by Th2 cells in asthma and results in the induction and recruitment of eosinophils from the peripheral circulation to the airways. IL-5 also promotes eosinophil differentiation, growth, and survival. […] The predominant airway inflammatory phenotype of pediatric asthma is eosinophilic, and this is independent of disease severity or duration. […] The inflammation is accompanied by the presence of structural airway wall changes, or airway remodeling.
- #44 Childhood asthma phenotypes and endotypes: a glance into the mosaic | Molecular and Cellular Pediatrics | Full Texthttps://molcellped.springeropen.com/articles/10.1186/s40348-023-00159-1
Noteworthy is the 17q12-21 locus, which has been replicated several times and is associated with early-onset asthma in childhood. […] The most common and best-described endotype is the T2-high (eosinophilic), which is also present in the adult population. This endotype has been described in children with mild, moderate, and severe asthma and is characterized by a high degree of atopy, increased eosinophils (in sputum and serum), high levels of T2 cytokines (IL-4, IL-5, and IL-13), and early signs of airway remodeling. […] The neutrophilic inflammatory endotype has been identified in children with STRA and is characterized by neutrophilic infiltration of the airways, where a Th1 or/and Th17 skewed immune profile has been implicated. […] In summary, different inflammatory endotypes have been described, and their detailed characterization may direct research towards new therapeutics and contribute to an adequate evidence-based selection of the best treatment for specific groups of asthmatic children.
- #45 Current Understanding of Asthma Pathogenesis and Biomarkershttps://www.mdpi.com/2073-4409/11/17/2764
Recent studies demonstrated that the airway epithelium produces cytokines in response to injury, infection, and pollutants. These epithelial-derived cytokines include thymic stromal lymphopoietin (TSLP), IL-25, and IL-33. TSLP, IL-25, and IL-33 activate type 2 innate lymphoid cells (ILC2), which generate Th2 cytokines, such as IL-5 and IL-13 and induce Th2 lung inflammation. […] IL-17 has been proposed to play an important role in Th2-low asthma. Variants in the IL-17 pathway genes may be related to asthma pathology. Higher levels of IL-17 are found in serum, sputum, and bronchoalveolar lavage fluid (BALF) of patients with asthma, which is associated with asthma severity. […] The role of IL-17 cytokines in asthma is still under investigation. IL-17 cytokines may stimulate epithelial cells and fibroblasts to release neutrophil chemoattractants CXCL1/5/8 and granulocyteâmacrophage colony-stimulating factor, which recruit neutrophils to the lungs. Furthermore, IL-17A, but not IL-17F, enhances airway smooth muscle contraction, migration, and proliferation, which facilitates airway hyperresponsiveness (AHR) and airway remodeling, key characteristics of asthma. […] However, there is accumulating evidence to suggest that inflammation-independent processes are also associated with asthma progression. For instance, recent studies demonstrate that protein kinases, adapter proteins, and other molecules contribute to asthma pathogenesis.
- #46 Current Understanding of Asthma Pathogenesis and Biomarkershttps://www.mdpi.com/2073-4409/11/17/2764
Recent studies demonstrated that the airway epithelium produces cytokines in response to injury, infection, and pollutants. These epithelial-derived cytokines include thymic stromal lymphopoietin (TSLP), IL-25, and IL-33. TSLP, IL-25, and IL-33 activate type 2 innate lymphoid cells (ILC2), which generate Th2 cytokines, such as IL-5 and IL-13 and induce Th2 lung inflammation. […] IL-17 has been proposed to play an important role in Th2-low asthma. Variants in the IL-17 pathway genes may be related to asthma pathology. Higher levels of IL-17 are found in serum, sputum, and bronchoalveolar lavage fluid (BALF) of patients with asthma, which is associated with asthma severity. […] The role of IL-17 cytokines in asthma is still under investigation. IL-17 cytokines may stimulate epithelial cells and fibroblasts to release neutrophil chemoattractants CXCL1/5/8 and granulocyteâmacrophage colony-stimulating factor, which recruit neutrophils to the lungs. Furthermore, IL-17A, but not IL-17F, enhances airway smooth muscle contraction, migration, and proliferation, which facilitates airway hyperresponsiveness (AHR) and airway remodeling, key characteristics of asthma. […] However, there is accumulating evidence to suggest that inflammation-independent processes are also associated with asthma progression. For instance, recent studies demonstrate that protein kinases, adapter proteins, and other molecules contribute to asthma pathogenesis.
- #47 Editorâs Pick: Sex Differences in Paediatric and Adult Asthma – European Medical Journalhttps://www.emjreviews.com/respiratory/article/editors-pick-sex-differences-in-paediatric-and-adult-asthma/
Asthma is the most common chronic condition in Western countries. Affecting 1 in 7 children and 1 in 12 adults, asthma is responsible for 350,000 avoidable deaths every year. […] While boys are more likely to develop asthma than girls, this pattern is reversed after puberty. This indicates that sex-specific factors, such as fluctuations in hormone levels, play a role in the diseases pathogenesis. […] The review will show that both experimental and epidemiological evidence suggest that circulating sex hormone levels are important contributors to asthma symptoms in post-pubertal females, while their role in males and children has not been yet established. In addition, the mechanisms associated with these hormonal influences on airway inflammation and hyper-reactivity have not been yet elucidated.
- #48 Editorâs Pick: Sex Differences in Paediatric and Adult Asthma – European Medical Journalhttps://www.emjreviews.com/respiratory/article/editors-pick-sex-differences-in-paediatric-and-adult-asthma/
The pathogenesis of the disease involves a number of mechanisms in different cell types, most of which remain understudied. Inflammation is a key component of asthma and involves early and late phase responses, which are characterised by the recruitment of specific immune cells. […] The observed sex differences of asthma incidence in children 18 years of age in the USA (9.2% in boys versus 7.2% in girls) and in adults (6.2% in men versus 10.4% in women) suggest that hormonal changes occurring during puberty may contribute to the increased incidence in adult women. […] Studies in animal models have suggested the involvement of sex hormones in mechanisms of lung inflammation and asthma. […] Together, these studies indicate that changes in oestrogen and androgen circulating levels might be the reason why asthma is more prevalent in females after reaching puberty. […] Overall, ovarian hormones have been found to increase, and testosterone to decrease, airway inflammation in asthma, but the mechanisms remain unclear. […] Despite this evidence, the specific mechanisms of action for sex hormones to promote or prevent asthma remain unclear.
- #49 Editorâs Pick: Sex Differences in Paediatric and Adult Asthma – European Medical Journalhttps://www.emjreviews.com/respiratory/article/editors-pick-sex-differences-in-paediatric-and-adult-asthma/
The pathogenesis of the disease involves a number of mechanisms in different cell types, most of which remain understudied. Inflammation is a key component of asthma and involves early and late phase responses, which are characterised by the recruitment of specific immune cells. […] The observed sex differences of asthma incidence in children 18 years of age in the USA (9.2% in boys versus 7.2% in girls) and in adults (6.2% in men versus 10.4% in women) suggest that hormonal changes occurring during puberty may contribute to the increased incidence in adult women. […] Studies in animal models have suggested the involvement of sex hormones in mechanisms of lung inflammation and asthma. […] Together, these studies indicate that changes in oestrogen and androgen circulating levels might be the reason why asthma is more prevalent in females after reaching puberty. […] Overall, ovarian hormones have been found to increase, and testosterone to decrease, airway inflammation in asthma, but the mechanisms remain unclear. […] Despite this evidence, the specific mechanisms of action for sex hormones to promote or prevent asthma remain unclear.
- #50 The Immunopathogenesis of Asthma | Thoracic Keyhttps://thoracickey.com/the-immunopathogenesis-of-asthma/
Development of allergic sensitization is a key component of asthma pathogenesis in children. Sensitization may develop to food or aero-allergens and is initiated at mucosal or barrier surfaces where there is an epithelial layer. […] The cytokines and chemokines released following eosinophil degranulation promote longevity of eosinophils in tissues, which leads to the cyclical nature of signaling, activation, and survival. […] IL-5 is released by Th2 cells in asthma and results in the induction and recruitment of eosinophils from the peripheral circulation to the airways. IL-5 also promotes eosinophil differentiation, growth, and survival. […] The predominant airway inflammatory phenotype of pediatric asthma is eosinophilic, and this is independent of disease severity or duration. […] The inflammation is accompanied by the presence of structural airway wall changes, or airway remodeling.
- #51 Asthma: Pathogenesis and Phenotypes | Thoracic Keyhttps://thoracickey.com/asthma-pathogenesis-and-phenotypes/
Asthma is a common disease whose prevalence has increased throughout the world for several decades. More recently, studies of the epidemiology, natural history, and pathogenesis have clearly demonstrated that asthma is a heterogeneous disease, with multiple etiologies and contributing cofactors, complex pathobiologic mechanisms, and different molecular phenotypes. Understanding these differences is critical for developing therapeutic strategies that will be effective for the various phenotypes of asthma. […] The strongest risk factor for asthma is a family history of atopy. This increases the risk of developing allergic rhinitis by fivefold and the risk of asthma by threefold to fourfold. In children 3 to 14 years old, both positive skin tests and increases in total serum IgE are strongly associated with asthma. Serum IgE also correlates strongly with bronchial hyperresponsiveness.
- #52 Asthma – Diagnosis – Management – Attacks – TeachMePaediatricshttps://teachmepaediatrics.com/respiratory/lower-respiratory-tract/asthma/
Asthma is a multi-factorial disease in which susceptible individuals have an exaggerated response to various stimuli. The disease process is driven by as vast array of mediators that lead to airway obstruction, and in more severe disease, airway remodelling. […] Classical allergic asthma is driven by Th2 type T-cells. Allergens are presented to these cells by dendritic cells, which in these individuals leads to a disproportionate immune response. […] The Th2 cells are activated by dendritic cells, and cytokines released from them result in the activation of the humoral immune system, with an increased proliferation of mast cells, eosinophils and dendritic cells as a result. […] In turn, cytokines released by these cell contribute to the underlying inflammatory process and bronchoconstriction. One particular example of this is leukotriene C4, which is directly toxic to epithelial cells. Other mediators further exacerbate the situation by favouring the production of an exudate, such as the histamine released from mast cells.
- #53 The role of regulatory B cells in immune regulation and childhood allergic asthma | Molecular and Cellular Pediatrics | Full Texthttps://molcellped.springeropen.com/articles/10.1186/s40348-023-00174-2
As the most common chronic disease in childhood, asthma displays a major public health problem worldwide with the incidence of those affected rising. As there is currently no cure for allergic asthma, it is mandatory to get a better understanding of the underlying molecular mechanism. […] By producing IgE antibodies upon allergen contact, B cells play a pivotal role in allergic asthma. Besides that, IL-10-secreting B cell subsets, namely regulatory B cells (Bregs), are reported in mice and humans to play a role in allergic asthma. […] Knowledge about the exact function of human Bregs in allergic asthma is still very limited. This review aims to summarize the current knowledge on Bregs. We discuss different human Breg subsets, several ways of Breg induction as well as the mechanisms through which they exert immunoregulatory functions, and their role in (childhood) allergic asthma.
- #54 The role of regulatory B cells in immune regulation and childhood allergic asthma | Molecular and Cellular Pediatrics | Full Texthttps://molcellped.springeropen.com/articles/10.1186/s40348-023-00174-2
Knowledge about the impact of B cells and Bregs on asthma is still rather limited. IgE production upon allergen contact is the main described role of B cells in allergic asthma, which is mandatory for the initiation of the allergic cascade. […] Allergic asthma is the predominant form of asthma in childhood, which has been characterized by sensitization to specific allergens, high IgE levels, eosinophilia, a type 2 shifted immune response, and decreased innate immunity gene expression. […] Recent research has concentrated on the role of Bregs in allergic asthma. As mentioned above, Bregs express the anti-inflammatory cytokine IL-10, which is thought to have a positive effect on asthma pathophysiology by suppressing the IgE-mediated allergic cascade and decreasing airway inflammation. […] It seems that Bregs are important for both children and adults with allergic asthma and that the appropriate number and function of Bregs may be mandatory to control asthma by releasing suppressive signals to decrease TH2 inflammation.
- #55 Advances in the pathogenesis and personalised treatment of paediatric asthma | BMJ Medicinehttps://bmjmedicine.bmj.com/content/2/1/e000367
The diversity of pathology of severe paediatric asthma demonstrates that the one-size-fits-all approach characterising many guidelines is inappropriate. […] Advances in the understanding of the underlying pathogenesis and the identification of clinical phenotypes and molecular endotypes has prompted a shift towards personalised treatment for children and young people with asthma. […] Healthcare professionals caring for children and young people with asthma should be aware of how to use objective measurements to make the diagnosis, and the advances in understanding of the pathogenesis of paediatric asthma that are substantially changing the management of asthma. […] The in-depth examination of the airway and identification of traits enables a better understanding of airway inflammation in asthma and identification of coexisting and alternative airway pathologies.
- #56 KLINIK RESPIRASI. Klinik Dokter THT di Malang, Klinik Dokter Paru di Malang, Klinik Jantung di Malang, Klinik Dokter Paru di Surabaya, Klinik Dokter Penyakit Dalam di Malang, Klinik Dokter Gigi di Malang, Klinik Dokter Gigi di Serponghttps://klinikrespirasimalang.com/news/3538-childhood-asthma–pathogenesis-and-phenotypes
Paediatric asthma phenotypes and endotypes may ultimately help to improve diagnosis of asthma, prediction of asthma development and treatment of individual children, based on clinical, temporal, developmental or inflammatory characteristics. […] The present knowledge on inflammatory phenotypes of childhood asthma has now been successfully applied in the treatment with biologicals of children with severe therapy resistant asthma, and it is to be expected that more personalized treatment options may become available.
- #57 Advances in the pathogenesis and personalised treatment of paediatric asthma | BMJ Medicinehttps://bmjmedicine.bmj.com/content/2/1/e000367
However, we now appreciate that „asthma” is an umbrella term comprising many different phenotypes and endotypes, and so The Lancet Commission defined asthma in purely clinical terms with no assumptions about the underlying pathology. […] The absence of these cytokines with persistent eosinophilia in severe, treatment resistant asthma has led to the hypothesis that innate mediators such as IL33, which appear to be relatively steroid resistant, could dominate the immune response in severe, treatment resistant asthma. […] In summary, not all paediatric severe asthma is driven by type 2 inflammation or will respond to anti-IL5 strategies. Critically determining what is driving the airway pathology is key to personalising treatment.
- #58 DUPIXENT® (dupilumab) Mechanism of Action For Asthmahttps://www.dupixenthcp.com/asthma/about/mechanism-of-action
DUPIXENT is the only dual inhibitor of IL-4 and IL-13 signaling, two of the key drivers of local and systemic type 2 inflammation in asthma. […] The mechanism of dupilumab action has not been definitively established. […] IL-13 is a key source of local type 2 inflammation. When activated, it contributes to epithelial barrier dysfunction, eosinophilic inflammation, mucus overproduction and smooth muscle contraction. […] IL-4 is a key source of systemic type 2 inflammation that causes eosinophil trafficking to the site of inflammation. Eosinophils release eosinophilic cationic protein or ECP, eosinophil peroxidase or EPO, and other chemical mediators that contribute to asthma pathology. […] DUPIXENT binds to the IL-4 receptor blocking IL-4 and IL-13 intracellular signaling. […] DUPIXENT also binds to the IL-13 receptor preventing IL-13 receptor binding with IL-13 as well as complexing of IL-13 receptor with the IL-4 receptor complex. […] IL-4 and IL-13 contribute to multiple systemic inflammatory effects in asthma. […] IL-4 and IL-13 contribute to multiple local inflammatory effects in the bronchial tubes.
- #59 Airway Remodeling Creates Susceptibility to Frequent Asthma Exacerbations in Children – Research Horizonshttps://scienceblog.cincinnatichildrens.org/airway-remodeling-creates-susceptibility-to-frequent-asthma-exacerbations-in-children/
The studyâs results suggest that more frequent asthma exacerbations donât lead to more severe exacerbations. Instead, repeated exacerbations result in neuronal airway remodeling that prime it to react the same way it has in the past. […] âOur findings highlight fundamental differences in these exacerbations and suggest that therapy targeting neuronal pathways may be necessary to adequately prevent and/or treat frequent exacerbations,â Khurana Hershey says.
- #60 Current Understanding of Asthma Pathogenesis and Biomarkershttps://www.mdpi.com/2073-4409/11/17/2764
Recent studies demonstrated that the airway epithelium produces cytokines in response to injury, infection, and pollutants. These epithelial-derived cytokines include thymic stromal lymphopoietin (TSLP), IL-25, and IL-33. TSLP, IL-25, and IL-33 activate type 2 innate lymphoid cells (ILC2), which generate Th2 cytokines, such as IL-5 and IL-13 and induce Th2 lung inflammation. […] IL-17 has been proposed to play an important role in Th2-low asthma. Variants in the IL-17 pathway genes may be related to asthma pathology. Higher levels of IL-17 are found in serum, sputum, and bronchoalveolar lavage fluid (BALF) of patients with asthma, which is associated with asthma severity. […] The role of IL-17 cytokines in asthma is still under investigation. IL-17 cytokines may stimulate epithelial cells and fibroblasts to release neutrophil chemoattractants CXCL1/5/8 and granulocyteâmacrophage colony-stimulating factor, which recruit neutrophils to the lungs. Furthermore, IL-17A, but not IL-17F, enhances airway smooth muscle contraction, migration, and proliferation, which facilitates airway hyperresponsiveness (AHR) and airway remodeling, key characteristics of asthma. […] However, there is accumulating evidence to suggest that inflammation-independent processes are also associated with asthma progression. For instance, recent studies demonstrate that protein kinases, adapter proteins, and other molecules contribute to asthma pathogenesis.
- #61 Common Childhood Asthma Not Rooted in Allergens, Inflammation | Columbia University Irving Medical Centerhttps://www.cuimc.columbia.edu/news/common-childhood-asthma-not-rooted-allergens-inflammation
Little is known about why asthma develops, how it constricts the airway, or why response to treatments varies among patients. […] Their report, in Science Translational Medicine, reveals that an overactive gene linked in 20 to 30 percent of patients with childhood asthma interrupts the synthesis of lipid molecules (known as sphingolipids) that are part of cell membranes found all over the body. […] Although the researchers do not yet understand why asthma results from reduced production of sphingolipids, their experiments clearly show a link between loss of these lipids and bronchial hyperreactivity, a key feature of asthma. […] What makes this pathway unique, investigators say, is that it is not related to allergens and has nothing to do with inflammation. […] Our model shows that asthma can result from having too little of a type of sphingolipids. This is a completely new pathway for asthma pathogenesis, says the studys senior author, Dr. Stefan Worgall, chief of the Pediatric Pulmonology, Allergy and Immunology Division at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
- #62 Asthma | Nature Reviews Disease Primershttps://www.nature.com/articles/nrdp201525
Asthma is the most common inflammatory disease of the lungs. The prevalence of asthma is increasing in many parts of the world that have adopted aspects of the Western lifestyle, and the disease poses a substantial global health and economic burden. Asthma involves both the large-conducting and the small-conducting airways, and is characterized by a combination of inflammation and structural remodelling that might begin in utero. Disease progression occurs in the context of a developmental background in which the postnatal acquisition of asthma is strongly linked with allergic sensitization. Most asthma cases follow a variable course, involving viral-induced wheezing and allergen sensitization, that is associated with various underlying mechanisms (or endotypes) that can differ between individuals. Each set of endotypes, in turn, produces specific asthma characteristics that evolve across the lifecourse of the patient. Strong genetic and environmental drivers of asthma interconnect through novel epigenetic mechanisms that operate prenatally and throughout childhood. Asthma can spontaneously remit or begin de novo in adulthood, and the factors that lead to the emergence and regression of asthma, irrespective of age, are poorly understood. Nonetheless, there is mounting evidence that supports a primary role for structural changes in the airways with asthma acquisition, on which altered innate immune mechanisms and microbiota interactions are superimposed. On the basis of the identification of new causative pathways, the subphenotyping of asthma across the lifecourse of patients is paving the way for more-personalized and precise pathway-specific approaches for the prevention and treatment of asthma, creating the real possibility of total prevention and cure for this chronic inflammatory disease.
- #63 Possible molecular mechanisms linking air pollution and asthma in children | BMC Pulmonary Medicine | Full Texthttps://bmcpulmmed.biomedcentral.com/articles/10.1186/1471-2466-14-31
Air pollution has many negative effects on pediatric health and it is recognised as a serious health hazard. There seems to be an association of air pollution with an increased risk of asthma exacerbations and acute respiratory infections. […] However, further studies are needed in order to clarify the specific mechanism of action of different air pollutants, identify genetic polymorphisms that modify airway responses to pollution, and investigate the effectiveness of new preventive and/or therapeutic approaches for subjects with low antioxidant enzyme levels. […] Moreover, as that epigenetic changes are inheritable during cell division and may be transmitted to subsequent generations, it is very important to clarify the role of epigenetics in the relationship between air pollution and lung disease in asthmatic and healthy children.